# Carboplatin in Patients With Progressive Gliomas

> **NCT00002749** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 25 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** carboplatin

## Key facts

- **NCT ID:** NCT00002749
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-02
- **Primary completion:** —
- **Final completion:** 2000-03
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2009-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002749, "Carboplatin in Patients With Progressive Gliomas". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*